Amgen
Contact information
Amgen, SA
Meritxell Mir, Comunicación Corporativa
World Trade Center Barcelona.Muelle Barcelona Edificio Sur, 7ª planta
Barcelona
Barcelona
936001900
933019009
Areas of activities
- A. Health Biotechnology
- Therapeutic areas
- Dermatology
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Inflammatory diseases
- Immunology
- Ophtalmology and optometry
- Oncology
- Blood and lymphatic system
- Kidney and genitourinary system
- Central nervous system
- Metabolic disorders / Endocrinology
Commissions
Our aim is to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.
Products and services
Oncology and hematology treatments. Amgen is developing research programs in nephrology, hematology, oncology, inflammatory diseases, metabolism and neuroscience.
Biotech Sanitaria
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| Xaluritamig | Biodrugs/ Drugs | Oncología | P I |
| tarlatamab | Biodrugs/ Drugs | Oncología | P I |
| romiplostim | Biodrugs/ Drugs | Sangre y sistema linfático | P III |
| Rocatinlimab | Biodrugs/ Drugs | Dermatología | P III |
| Repatha | Biodrugs/ Drugs | Enfermedades cardiovasculares y sistema circulatorio | P III |
| Evenity | Biodrugs/ Drugs | Enfermedades genéticas y raras | P I |
| Olpasiran | Biodrugs/ Drugs | Enfermedades cardiovasculares y sistema circulatorio | P III |
| etelcalcetida | Biodrugs/ Drugs | Sangre y sistema linfático | P III |
| blinatumomab | Biodrugs/ Drugs | Sangre y sistema linfático | P III |
| bemarituzumab | Biodrugs/ Drugs | Oncología | P I |
| apremilast | Biodrugs/ Drugs | Inmunología | P III |
| apremilast | Biodrugs/ Drugs | Inmunología | P III |
| AMG 404 | Biodrugs/ Drugs | Oncología | P I |
| AMG 305 | Biodrugs/ Drugs | Oncología | P I |
| AMG 256 | Biodrugs/ Drugs | Oncología | P I |
| AMG 133 | Biodrugs/ Drugs | Trastornos metabólicos / Endocrinología | P II |
| acapatamab | Biodrugs/ Drugs | Oncología | P II |
| erenumab | Biodrugs/ Drugs | Analgesia / Dolor, Sistema nervioso central | Registration |
| erenumab | Biodrugs/ Drugs | Analgesia / Dolor, Sistema nervioso central | Registration |
| tarlatamab | Biodrugs/ Drugs | Oncología, Sistema respiratorio y pulmonar | P III |
| sotorasib | Biodrugs/ Drugs | Oncología, Sistema respiratorio y pulmonar | P III |
| sotorasib | Biodrugs/ Drugs | Oncología, Sistema respiratorio y pulmonar | P III |
| bemarituzumab | Biodrugs/ Drugs | Oncología, Sistema digestivo y hepatología | P III |
| sotorasib | Biodrugs/ Drugs | Oncología, Sistema digestivo y hepatología | P III |
| carfilzomib | Biodrugs/ Drugs | Sangre y sistema linfático, Oncología | P III |